Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer

Cancer. 2020 Jul 15;126(14):3174-3175. doi: 10.1002/cncr.32919. Epub 2020 Apr 23.

Abstract

The alarming situation of the 2019 novel coronavirus disease (COVID‐19) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer. This commentary proposes a simple 5‐part strategy plus rapidly expanded use of telemedicine to anticipate and deal with COVID‐19 and, by extension, future epidemics in patients with cancer.

Keywords: COVID-19; infectious disease; pandemic; telehealth; telemedicine.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / transmission
  • Female
  • Humans
  • Male
  • Mass Screening / methods
  • Medicare / economics
  • Medicare / legislation & jurisprudence
  • Middle Aged
  • Neoplasms / therapy*
  • Oncologists / psychology
  • Pandemics / prevention & control*
  • Personal Protective Equipment
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / transmission
  • Quarantine
  • SARS-CoV-2
  • Telemedicine / economics
  • Telemedicine / methods*
  • Triage / methods
  • United States / epidemiology